CDSCO Expert Panel recommends emergency use of Covaxin for children aged 2-18

New Delhi: The CDSCO (Central Medicines Standards Control Organization) expert committee has approved the administration of Covaxin to children between the ages of 2 and 18, according to official sources. After a meeting yesterday, the SEC sent its recommendation to the Drug Controller General of India for approval. Phase II and III trials were conducted …

CDSCO Expert Panel recommends emergency use of Covaxin for children aged 2-18 Read More »